Spleen-preserving distal pancreatectomy following neoadjuvant chemotherapy for papillary solid and cystic neoplasm of pancreas.
Papillary solid and cystic neoplasm (PSCN) is a rare neoplasm of the pancreas with low-grade malignant potential and favorable prognosis. We report an 18-year-old girl with PSCN presenting with advanced disease. The tumor regressed with six cycles of gemcitabine and cisplantin-based neoadjuvant chemotherapy; spleen-preserving distal pancreatectomy was then done. She is disease-free at 13 months' follow-up.
Das
Ganesh
G
Department of Surgical Oncology, Dr Bhabaneswar Borooah Cancer Institute, Gopinath Nagar, Guwahati-781 016, Assam, India. gdas7798@indiatimes.com
Bhuyan
Chidananda
C
Das
Bhabesh Kumar
BK
Sharma
Jagannath Deb
JD
Saikia
Bhargab Jyoti
BJ
Purkystha
Joydeep
J
D015746:Abdominal Pain / Q000175:diagnosis / Q000209:etiology; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D003131:Combined Modality Therapy; D018292:Cystadenoma, Papillary / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D020360:Neoadjuvant Therapy; D010180:Pancreatectomy / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D018570:Risk Assessment; D013154:Spleen; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome